Anúncio
Anúncio
MLYS
Mineralys Therapeutics, Inc. Common Stock
35.70
USDPatrocinado
-0.59
-1.64%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
35.78
+0.08
+0.24%
Relatórios de Lucros MLYS
Rácio de surpresa positiva
MLYS separação 9 de 12 últimas estimativas.
75%
Próximo Relatório
Data do Próximo Relatório
10 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.58
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+11.54%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-40.82%
Mineralys Therapeutics, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, MLYS reported earnings of -0.52 USD per share (EPS) for Q3 25, beating the estimate of -0.63 USD, resulting in a 17.77% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -0.58 USD, with revenue projected to reach -- USD, implying an aumentar of 11.54% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Mineralys Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Mineralys Therapeutics, Inc. Common Stock reported EPS of -$0.52, beating estimates by 17.77%, and revenue of $0.00, 0% as expectations.
How did the market react to Mineralys Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 5.87%, changed from $44.50 before the earnings release to $47.11 the day after.
When is Mineralys Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 10 de fev. de 2026.
What are the forecasts for Mineralys Therapeutics, Inc. Common Stock's next earnings report?
Based on 10
analistas, Mineralys Therapeutics, Inc. Common Stock is expected to report EPS of -$0.58 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio